HOME >> BIOLOGY >> NEWS
Fox Chase Cancer Center scientists identify immune-system mutation

PHILADELPHIA (Feb. 24, 2005)--A team of Fox Chase Cancer Center scientists led by immunologist Dietmar J. Kappes, Ph.D., has identified the genetic mutation that keeps a mouse strain from developing white blood cells, or lymphocytes, called helper T cells. The report by Kappes and his colleagues appears in the Feb. 24 issue of Nature.

Kappes' laboratory first discovered the mice with this naturally occurring defect in Fox Chase's laboratory animal facility in 1997. Known as "helper deficient" or HD mice, they are proving to be useful for exploring the pathways of lymphocyte development, according to Kappes.

Helper T cells, so called because they arise from the thymus gland, are essential for combating intracellular viral and bacterial infections (cell-mediated immunity) and also for helping other white blood cells (B cells, derived from bone marrow) generate antibodies against foreign agents that enter the body. Other T cells are known as killer cells because they attack foreign invaders more directly.

"The maturation of T cells involves key branch points at which cells choose one of two different pathways, going on to become helper cells or killer cells," Kappes said. His goal is to understand how T cells specialize to do different jobs.

Commitment to the helper or killer lineages correlates precisely with the restriction of the T-cell receptor toward either class I or class II major histocompatibility complex (MHC) molecules. Most helper T cells carry a surface protein called CD4, which is attracted to class II MHC. Killer cells carry the CD8 protein, attracted to class I MHC. However, the underlying molecular pathways that regulate this process have remained obscure.

"The mutant HD mice are unable to generate mature helper
'"/>

Contact: Karen Carter Mallet
Karen.Mallet@fccc.edu
215-728-2700
Fox Chase Cancer Center
24-Feb-2005


Page: 1 2 3

Related biology news :

1. DoD awards $10.7 million Center of Excellence Grant to Fox Chases V. Craig Jordan
2. Fox Chase study sheds light on cancer susceptibility and disease involving bone-marrow failure
3. Fox Chase Cancer Center study shows that inhibitors of (FAP) attenuate tumor growth in mice
4. Symposium honors achievements of Fox Chase Cancer Center Nobel Laureate Baruch Blumberg
5. Fox Chase study shows that weakened T-cell receptor signals change T-cell lineage
6. Fox Chase Cancer Center researchers: Selenium will have critical role in prostate cancer treatment
7. Fox Chase Cancer Center researchers identify subset of ovarian cancer patients responsive to Iressa
8. Fox Chase Cancer Center researchers look for silenced genes to monitor kidney cancer patients
9. Fox Chase Cancer Center scientists discover key proteins linked to aging and cancer
10. Journalists can register now for ECCO 14 -- the European Cancer Conference
11. Cancer cures could work for canines and humans

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/4/2019)... ... June 04, 2019 , ... ... for salient features of seizure risk signals, usually based on variations of amplitude, ... remains the only acceptable diagnostic methodology due to the complexity and variability of ...
(Date:6/1/2019)... ... 2019 , ... The University of Vermont Health Network Ventures ... Series B Financing Round. , “With the commitment from the UVM fund ... and business resources to bear as we advance our biopharmaceutical products to the ...
(Date:5/31/2019)... (PRWEB) , ... May 30, 2019 , ... ... Comprehend in a live webinar on Wednesday, June 19, 2019 ... clinical operations teams, medical review teams, data management teams and contract research organizations ...
Breaking Biology News(10 mins):
(Date:6/11/2019)... , ... June 11, 2019 , ... ... Personalized Stem Cells Inc. (PSC) , has announced that their GMP facility ... Food and Drug Branch for manufacturing. This is an important milestone for ...
(Date:5/31/2019)... ... May 29, 2019 , ... For many years, the ... forms of cancer demand breakthrough therapies. Advances in immuno-oncology have led to the advent ... T cells with engineered T cell receptors known as “CARs”. The CAR enables the ...
(Date:5/31/2019)... ... May 30, 2019 , ... Object Pharma, Inc., ... strategic acquisition of Metabiologics, Inc., a globally recognized leader in the production and ... commercialization rights to a full spectrum of botulinum neurotoxins, as well as a ...
(Date:5/21/2019)... ... 21, 2019 , ... DuPont Nutrition & Biosciences (DuPont) and ... Brewing Conference dedicated to sharing brewing knowledge, strengthening relationships and discussing best practices ... through a partnership with “Ethiopia Invest”, will run through May 23, 2019, in ...
Breaking Biology Technology:
Cached News: